Protagonist Therapeutics (PTGX) total assets

Total assets · fiscal 2025
$668.19M

Protagonist Therapeutics (PTGX) had total assets of $668.19M at the end of fiscal 2025 (December 31, 2025). That is 10.3% lower than the $744.73M of fiscal 2024. Figures as of 19 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$668.19M
Change on fiscal 2024
−10.3%
Growth, 5 years
+15.5% a year
Growth, 10 years
+46.3% a year
Highest on record
$744.73Mfiscal 2024
Lowest on record
$14.85Mfiscal 2015
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Protagonist Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 15.5% a year; over ten years the rate was 46.3% a year. Across the 11 fiscal years on record (2015–2025), the highest was $744.73M in fiscal 2024 and the lowest $14.85M in fiscal 2015.

History · 11 fiscal years

Total assets by fiscal year

Protagonist Therapeutics total assets, year by year

Protagonist Therapeutics (PTGX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$668.19M 10.3% down
2024$744.73M 108.1% up
2023$357.95M 44.4% up
2022$247.93M 28.7% down
2021$347.70M 7.2% up
2020$324.47M 109.4% up
2019$154.92M 11.1% up
2018$139.47M 14.8% down
2017$163.73M 74.2% up
2016$93.99M 533.1% up
2015$14.85M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Protagonist Therapeutics and comparable companies
CompanyTotal assetsFiscal year
Protagonist Therapeutics PTGX$668.19M2025
Krystal Biotech KRYS$1.33B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTGX

Protagonist Therapeutics, figure by figure

Protagonist Therapeutics (PTGX) overview: price, valuation and scorecardAll health care companies by market value

Protagonist Therapeutics total assets: questions and answers

How large are Protagonist Therapeutics's total assets?

Protagonist Therapeutics (PTGX) had total assets of $668.19M at the end of fiscal 2025 (December 31, 2025). That is 10.3% lower than the $744.73M of fiscal 2024.

What is the growth rate of Protagonist Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 15.5% a year; over ten years the rate was 46.3% a year.

What are the highest and lowest total assets figures on record for Protagonist Therapeutics?

Across the 11 fiscal years on record (2015–2025), the highest was $744.73M in fiscal 2024 and the lowest $14.85M in fiscal 2015.

How is Protagonist Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Protagonist Therapeutics it is on record here for 11 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Protagonist Therapeutics (PTGX) total assets”, data as of 19 November 2026. https://funkfolio.com/stock/PTGX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.